A synthetic peptide for use as a blocking control in assays to test for specificity of RPL13 antibody, Alternative Names: RPL13 control peptide, RPL13 antibody Blocking Peptide, Anti-RPL13 Blocking Peptide, Ribosomal Protein L13 Blocking Peptide, BBC1 Blocking Peptide, D16S444E Blocking Peptide, FLJ27453 Blocking Peptide, FLJ27454 Blocking Peptide, MGC117342 Blocking Peptide, MGC71373 Blocking Peptide, RPL13, RPL-13, RPL 13, RPL-13 Blocking Peptide, RPL 13 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
RPL13
(Ribosomal Protein L13 (RPL13))
Hintergrund
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. RPL13 is a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L13E family of ribosomal proteins. It is located in the cytoplasm. This gene is expressed at significantly higher levels in benign breast lesions than in breast carcinomas.